286 related articles for article (PubMed ID: 9482575)
21. Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene.
Christianto A; Watanabe H; Nakajima T; Inazu T
Clin Chim Acta; 2013 Aug; 423():66-8. PubMed ID: 23726270
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome).
Popowska E; Rathmann M; Tylki-Szymanska A; Bunge S; Steglich C; Schwinger E; Gal A
Hum Mutat; 1995; 5(1):97-100. PubMed ID: 7728156
[No Abstract] [Full Text] [Related]
23. Mucopolysaccharidosis type II (Hunter disease): identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.
Sukegawa K; Tomatsu S; Fukao T; Iwata H; Song XQ; Yamada Y; Fukuda S; Isogai K; Orii T
Hum Mutat; 1995; 6(2):136-43. PubMed ID: 7581397
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene.
Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA
J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617
[TBL] [Abstract][Full Text] [Related]
25. A deletion involving exons 2-4 in the iduronate-2-sulfatase gene of a patient with intermediate Hunter syndrome.
Bonuccelli G; Regis S; Filocamo M; Corsolini F; Caroli F; Gatti R
Clin Genet; 1998 Jun; 53(6):474-7. PubMed ID: 9712538
[TBL] [Abstract][Full Text] [Related]
26. Molecular investigations of a novel iduronate-2-sulfatase mutant in a Chinese patient.
Lau KC; Lam CW
Clin Chim Acta; 2008 Jun; 392(1-2):8-10. PubMed ID: 18331837
[TBL] [Abstract][Full Text] [Related]
27. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.
Jonsson JJ; Aronovich EL; Braun SE; Whitley CB
Am J Hum Genet; 1995 Mar; 56(3):597-607. PubMed ID: 7887413
[TBL] [Abstract][Full Text] [Related]
29. Hunter syndrome: gene deletions and rearrangements.
Froissart R; Blond JL; Maire I; Guibaud P; Hopwood JJ; Mathieu M; Bozon D
Hum Mutat; 1993; 2(2):138-40. PubMed ID: 8318991
[No Abstract] [Full Text] [Related]
30. Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome).
Bunge S; Steglich C; Beck M; Rosenkranz W; Schwinger E; Hopwood JJ; Gal A
Hum Mol Genet; 1992 Aug; 1(5):335-9. PubMed ID: 1303211
[TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of the cDNA for the murine iduronate sulfatase gene.
Daniele A; Faust CJ; Herman GE; Di Natale P; Ballabio A
Genomics; 1993 Jun; 16(3):755-7. PubMed ID: 8325651
[TBL] [Abstract][Full Text] [Related]
32. General implications for CpG hot spot mutations: methylation patterns of the human iduronate-2-sulfatase gene locus.
Tomatsu S; Orii KO; Bi Y; Gutierrez MA; Nishioka T; Yamaguchi S; Kondo N; Orii T; Noguchi A; Sly WS
Hum Mutat; 2004 Jun; 23(6):590-8. PubMed ID: 15146464
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene.
Hopwood JJ; Bunge S; Morris CP; Wilson PJ; Steglich C; Beck M; Schwinger E; Gal A
Hum Mutat; 1993; 2(6):435-42. PubMed ID: 8111411
[TBL] [Abstract][Full Text] [Related]
34. Presence of an IDS-related locus (IDS2) in Xq28 complicates the mutational analysis of Hunter syndrome.
Bondeson ML; Malmgren H; Dahl N; Carlberg BM; Pettersson U
Eur J Hum Genet; 1995; 3(4):219-27. PubMed ID: 8528670
[TBL] [Abstract][Full Text] [Related]
35. IDS gene-pseudogene exchange responsible for an intragenic deletion in a Hunter patient.
Birot AM; Bouton O; Froissart R; Maire I; Bozon D
Hum Mutat; 1996; 8(1):44-50. PubMed ID: 8807335
[TBL] [Abstract][Full Text] [Related]
36. Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.
Olsen TC; Eiken HG; Knappskog PM; Kase BF; Månsson JE; Boman H; Apold J
Hum Genet; 1996 Feb; 97(2):198-203. PubMed ID: 8566953
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of patients with Hunter syndrome: implication of a region prone to structural alterations within the IDS gene.
Steén-Bondeson ML; Dahl N; Tönnesen T; Kleijer WJ; Seidlitz G; Gustavson KH; Wilson PJ; Morris CP; Hopwood JJ; Pettersson U
Hum Mol Genet; 1992 Jun; 1(3):195-8. PubMed ID: 1303177
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation.
Li P; Thompson JN; Hug G; Huffman P; Chuck G
Am J Med Genet; 1996 Sep; 64(4):531-5. PubMed ID: 8870917
[TBL] [Abstract][Full Text] [Related]
39. A novel mutation of IDS gene in a Chinese patient with mucopolysaccharidosis II by next-generation sequencing.
Wei X; Jin F; Ye Y; Xu C; Qu N; Ju X; Yi X
Clin Chim Acta; 2011 Nov; 412(23-24):2340-2. PubMed ID: 21910981
[TBL] [Abstract][Full Text] [Related]
40. [Detection of a new mutation (T1140C)in a Chinese Guangdong patient with hunter syndrome].
Guo YB; Du CS
Yi Chuan; 2006 May; 28(5):521-4. PubMed ID: 16735228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
